NEW BETA CELL-SPECIFIC MEMBRANE PROTEIN RELEVANT TO IDDM
与 IDDM 相关的新 Beta 细胞特异性膜蛋白
基本信息
- 批准号:3245074
- 负责人:
- 金额:$ 18.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1991
- 资助国家:美国
- 起止时间:1991-07-01 至 1994-08-31
- 项目状态:已结题
- 来源:
- 关键词:affinity chromatography autoantibody autoantigens cellular immunity diabetes mellitus genetics embryo /fetus protein embryo /fetus tissue /cell culture genetic library genetic polymorphism genetic regulation growth /development human tissue immunocytochemistry immunoprecipitation insulin dependent diabetes mellitus intracellular transport laboratory mouse laboratory rat membrane proteins molecular cloning monoclonal antibody northern blottings nucleic acid probes pancreatic islets posttranslational modifications protein biosynthesis protein purification protein structure function restriction mapping southern blotting tissue /cell culture transfection western blottings
项目摘要
Insulin-dependent diabetes mellitus is a common, potentially lethal
disease that strikes approximately 1 in 10,000 children under the age of
20 in the United States each year. The cause of this disease is an
absolute, irreversible loss of the insulin-producing beta cells of the
pancreatic islets, but, the mechanism of the destruction of the beta
cells is unknown. Many lines of evidence have pointed to autoimmunity
as the most likely cause of the beta cell loss. The most consistent
finding in this juvenile form of diabetes is the presence of
autoantibodies against the islet cells. There has been difficulty in
taking advantage of these islet cell antibodies to study the mechanism
of diabetes as they are believed to bind to a number of different auto-
antigens whose structure and properties are incompletely known. More-
over, the functions of these autoantigenic substances are also largely
unknown. We have discovered a mouse monoclonal antibody that binds to
the same antigen on rat beta cells that most children with diabetes also
make autoantibodies to. We have learned that these antibodies bind to a
membrane protein that is found only in the beta cells of the pancreas.
Protein is large with a molecular weight of approximately 150,000. We
have also been able to isolate messenger RNA from the pancreas which can
synthesize this protein in vitro. We propose to take advantage of the
discovery of this monoclonal antibody and this novel beta cell protein
to understand the structure of the protein and its gene, to explore the
possible functional roles for the protein and the regulation of its
expression in the normal beta cell, to determine whether this protein
might serve as a target for the cell-mediated arm of the immune system
which has been shown to be responible for beta cell killing in the
animal models of insulin-dependent diabetes, and, lastly, to ascertain
whether differences in the gene for this protein may contribute to the
genetic susceptibility for diabetes.
胰岛素依赖型糖尿病是一种常见的潜在致命性疾病
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT C MCEVOY其他文献
ROBERT C MCEVOY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT C MCEVOY', 18)}}的其他基金
SOMATIC GENE THERAPY FOR TYPE 1 DIABETES MELLITUS
1 型糖尿病的体细胞基因疗法
- 批准号:
2774160 - 财政年份:1999
- 资助金额:
$ 18.59万 - 项目类别:
NEW BETA CELL-SPECIFIC MEMBRANE PROTEIN RELEVANT TO IDDM
与 IDDM 相关的新 Beta 细胞特异性膜蛋白
- 批准号:
3245073 - 财政年份:1991
- 资助金额:
$ 18.59万 - 项目类别:
NEW BETA CELL-SPECIFIC MEMBRANE PROTEIN RELEVANT TO IDDM
与 IDDM 相关的新 Beta 细胞特异性膜蛋白
- 批准号:
2143133 - 财政年份:1991
- 资助金额:
$ 18.59万 - 项目类别:
相似海外基金
Immunomodulatory effects of desmoglein 3 chimeric autoantibody receptor T cells (DSG3-CAART) in mucosal pemphigus vulgaris
桥粒芯糖蛋白 3 嵌合自身抗体受体 T 细胞 (DSG3-CAART) 对粘膜寻常型天疱疮的免疫调节作用
- 批准号:
10679911 - 财政年份:2023
- 资助金额:
$ 18.59万 - 项目类别:
Elucidating the immunology of autoantibody formation and function in COVID-19
阐明 COVID-19 中自身抗体形成和功能的免疫学
- 批准号:
10639707 - 财政年份:2023
- 资助金额:
$ 18.59万 - 项目类别:
Clinical application based on the molecular mechanism of autoantibody production in autoimmunity
基于自身抗体产生的分子机制在自身免疫中的临床应用
- 批准号:
23K18361 - 财政年份:2023
- 资助金额:
$ 18.59万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Analysis of abnormal post-translational modifications that promote autoantibody production using high-precision mass spectrometry
使用高精度质谱分析促进自身抗体产生的异常翻译后修饰
- 批准号:
23K07915 - 财政年份:2023
- 资助金额:
$ 18.59万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Dynamic prediction of type 1 diabetes risk and autoantibody status by a joint model of longitudinal and multistate models
通过纵向和多状态模型的联合模型动态预测1型糖尿病风险和自身抗体状态
- 批准号:
10630731 - 财政年份:2023
- 资助金额:
$ 18.59万 - 项目类别:
Novel therapeutic strategies targeting autoantibody-producing RP105-negative B cells by t-SNE method
通过 t-SNE 方法针对产生自身抗体的 RP105 阴性 B 细胞的新治疗策略
- 批准号:
23K07910 - 财政年份:2023
- 资助金额:
$ 18.59万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Extracellular vesicle and autoantibody production
细胞外囊泡和自身抗体的产生
- 批准号:
23K15265 - 财政年份:2023
- 资助金额:
$ 18.59万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of mechanism of autoantibody production in pemphigus in conjunction with information from single cell analysis
结合单细胞分析信息阐明天疱疮自身抗体产生的机制
- 批准号:
22K08416 - 财政年份:2022
- 资助金额:
$ 18.59万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Influence of HTLV-1 for autoantibody production system and Th subset
HTLV-1对自身抗体产生系统和Th亚群的影响
- 批准号:
22K08552 - 财政年份:2022
- 资助金额:
$ 18.59万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Multi-Platform Homogeneous Multiplexed Autoantibody Assay Based on Liquid Micropiston-Enhanced Time-Resolved Forster Resonance Energy Transfer
基于液体微活塞增强时间分辨福斯特共振能量转移的多平台同质多重自身抗体测定
- 批准号:
10576777 - 财政年份:2022
- 资助金额:
$ 18.59万 - 项目类别:














{{item.name}}会员




